AIET - outcomes of Randomized Clinical trials
1. Fujita K, Ikarashi H, Takakuwa K, Kodama S, Tokunaga A, Takahashi T, Tanaka K. Prolonged disease-free period in patients with advanced epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes. Clin Cancer Res. 1995
Type of cancer: Ovarian Cancer
No. of patients: 13 patients were given AIET along with surgical resection and chemotherapy. 11 patients treated with only surgical resection and chemotherapy were kept as controls
Inference: Patients who were treated with AIET had increased survival rate and increased disease free survival rate (P<0.01; P<0.05)
Type of cancer: Lung cancer (Stage II-IV)
No. of patients: 82 patients were given AIET along with resection and chemotherapy/radiotherapy. 88 patients treated with only surgical resection and chemotherapy/radiotherapy were kept as controls
Inference: Patients who were treated with AIET had increased survival rate (P<0.001)
Type of Cancer: Liver cancer
No. of patients: 74 patients were given AIET after surgical resection. 76 patients treated with only surgical resection were kept as controls
inference: Patients who were treated with AIET had increased survival rate and increased disease free survival rate (P<0.09; P<0.01)
Type of Cancer: Stomach cancer (Stage-IV)
No. of patients: 22 patients were given AIET along with Chemotherapy. 22 patients treated with only chemotherapy were kept as controls
Inference: Patients who were treated with AIET had increased survival rate (P<0.05)